Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Kaiyue Yu, Yixuan Wang, Tao Wan, Yuanhao Zhai, Sisi Cao, Wenyi Ruan, Chuanbin Wu & Yuehong Xu. (2018) Tacrolimus nanoparticles based on chitosan combined with nicotinamide: enhancing percutaneous delivery and treatment efficacy for atopic dermatitis and reducing dose. International Journal of Nanomedicine 13, pages 129-142.
Read now
Read now
In-Hwan Baek, Byung-Yo Lee, Jung-Woo Chae, Gyu Yong Song, Wonku Kang & Kwang-Il Kwon. (2014) Development of a pharmacokinetic/pharmacodynamic/disease progression model in NC/Nga mice for development of novel anti-atopic dermatitis drugs. Xenobiotica 44:11, pages 975-987.
Read now
Read now
Articles from other publishers (40)
Anne Sofie FrølundeChristian Vestergaard. (2023) Reactive and proactive treatment in atopic dermatitis: Long-term disease control. Indian Journal of Skin Allergy 2, pages 45-50.
Crossref
Crossref
Hidehisa Saeki, Yukihiro Ohya, Junichi Furuta, Hirokazu Arakawa, Susumu Ichiyama, Toshio Katsunuma, Norito Katoh, Akio Tanaka, Yuichiro Tsunemi, Takeshi Nakahara, Mizuho Nagao, Masami Narita, Michihiro Hide, Takao Fujisawa, Masaki Futamura, Koji Masuda, Tomoyo Matsubara, Hiroyuki Murota & Kiwako Yamamoto‐Hanada. (2022) English Version of Clinical Practice Guidelines for the Management of Atopic Dermatitis 2021. The Journal of Dermatology 49:10.
Crossref
Crossref
Badar Uddin Umar, Sayeeda Rahman, Siddhartha Dutta, Tariqul Islam, Nadia Nusrat, Kona Chowdhury, Wan Farizatul Shima Binti Wan Ahmad Fakuradzi & Mainul Haque. (2022) Management of Atopic Dermatitis: The Role of Tacrolimus. Cureus.
Crossref
Crossref
Meseret Ewunetu Kibret, Tatek Temesgen Terfasa & Melakuu Tesfaye Alemea. (2022) In-situ oligomerization of lactic acid within broiler skin extracted elastin/collagen matrix for the efficacy of ointment base. Heliyon 8:8, pages e10346.
Crossref
Crossref
Anne Sofie Frølunde, Jacob Pontoppidan Thyssen, Mette Deleuran & Christian Vestergaard. (2021) Appraisal of Proactive Topical Therapy in Atopic Dermatitis: Pros and Cons. American Journal of Clinical Dermatology 22:6, pages 775-783.
Crossref
Crossref
Marissa T. Ayasse, Adnan Ahmed, Maria L. Espinosa, Christina J. Walker, Muhammad Yousaf, Jacob P. Thyssen & Jonathan I. Silverberg. (2020) What are the highest yielding search strategy terms for systematic reviews in atopic dermatitis? A systematic review. Archives of Dermatological Research 313:9, pages 737-750.
Crossref
Crossref
Aswatha Rabindranathnambi & Maaz Abid. (2021) Topical treatments in dermatology. British Journal of Hospital Medicine 82:8, pages 1-9.
Crossref
Crossref
Emma Axon, Joanne R Chalmers, Miriam Santer, Matthew J Ridd, Sandra Lawton, Sinead M Langan, Douglas J C Grindlay, Ingrid Muller, Amanda Roberts, Amina Ahmed, Hywel C Williams & Kim S Thomas. (2021) Safety of topical corticosteroids in atopic eczema: an umbrella review. BMJ Open 11:7, pages e046476.
Crossref
Crossref
David Luk, Kam Lun Ellis Hon, Maria Victoria C. Dizon, Kin-Fon Leong, Yong-Kwang Tay, Mark Jean-Aan Koh, Nisha Suyien Chandran, Siriwan Wananukul, Susheera Chatproedprai & Thomas Luger. (2020) Practical Recommendations for the Topical Treatment of Atopic Dermatitis in South and East Asia. Dermatology and Therapy 11:1, pages 275-291.
Crossref
Crossref
Ahmad Chehade & Jaggi Rao. 2021. Comprehensive Dermatologic Drug Therapy. Comprehensive Dermatologic Drug Therapy
549
556.e5
.
S.‐L. Sun, J.‐J. Liu, B. Zhong, J.‐K. Wang, X. Jin, H. Xu, F.‐Y. Yin, T.‐N. Liu, Q.‐M. Chen & X. Zeng. (2019) Topical calcineurin inhibitors in the treatment of oral lichen planus: a systematic review and meta‐analysis. British Journal of Dermatology 181:6, pages 1166-1176.
Crossref
Crossref
Norito Katoh, Yukihiro Ohya, Masanori Ikeda, Tamotsu Ebihara, Ichiro Katayama, Hidehisa Saeki, Naoki Shimojo, Akio Tanaka, Takeshi Nakahara, Mizuho Nagao, Michihiro Hide, Yuji Fujita, Takao Fujisawa, Masaki Futamura, Koji Masuda, Hiroyuki Murota & Kiwako Yamamoto‐Hanada. (2019) Clinical practice guidelines for the management of atopic dermatitis 2018. The Journal of Dermatology 46:12, pages 1053-1101.
Crossref
Crossref
Sam Hanna, Catherine Zip & Neil H. Shear. (2019) What Is the Risk of Harm Associated With Topical Calcineurin Inhibitors?. Journal of Cutaneous Medicine and Surgery 23:4_suppl, pages 19S-26S.
Crossref
Crossref
Tomo Kita, Kunitoshi Uchida, Kenichi Kato, Yoshiro Suzuki, Makoto Tominaga & Jun Yamazaki. (2018) FK506 (tacrolimus) causes pain sensation through the activation of transient receptor potential ankyrin 1 (TRPA1) channels. The Journal of Physiological Sciences 69:2, pages 305-316.
Crossref
Crossref
Mamitaro Ohtsuki, Hiroshi Morimoto & Hidemi Nakagawa. (2018) Tacrolimus ointment for the treatment of adult and pediatric atopic dermatitis: Review on safety and benefits. The Journal of Dermatology 45:8, pages 936-942.
Crossref
Crossref
Luz de María Díaz Granados, María Adelaida Quijano, Paola Andrea Ramírez, Natalia Aguirre & Gloria Sanclemente. (2017) Quality assessment of atopic dermatitis clinical practice guidelines in ≤ 18 years. Archives of Dermatological Research 310:1, pages 29-37.
Crossref
Crossref
Mi-Sung Park, Nho-Eul Song, Sang-Ho Baik, Hyun-Ock Pae & Seong Hoon Park. (2017) Oral administration of lactobacilli isolated from Jeotgal, a salted fermented seafood, inhibits the development of 2,4-dinitrofluorobenzene-induced atopic dermatitis in mice. Experimental and Therapeutic Medicine 14:1, pages 635-641.
Crossref
Crossref
Atsushi Noguchi, Mitsutoshi Tominaga, Nobuaki Takahashi, Hironori Matsuda, Yayoi Kamata, Yoshie Umehara, Kyi Chan Ko, Yasushi Suga, Hideoki Ogawa & Kenji Takamori. (2017) Differences in therapeutic effects of topically applied corticosteroid and tacrolimus on atopic dermatitis-like symptoms in NC/Nga mice. Journal of Dermatological Science 86:1, pages 54-62.
Crossref
Crossref
Kim S Thomas, Jonathan M Batchelor, Fiona Bath-Hextall, Joanne R Chalmers, Tessa Clarke, Sally Crowe, Finola M Delamere, Viktoria Eleftheriadou, Nicholas Evans, Lester Firkins, Nicola Greenlaw, Louise Lansbury, Sandra Lawton, Carron Layfield, Jo Leonardi-Bee, James Mason, Eleanor Mitchell, Helen Nankervis, John Norrie, Andrew Nunn, Anthony D Ormerod, Ramesh Patel, William Perkins, Jane C Ravenscroft, Jochen Schmitt, Eric Simpson, Maxine E Whitton & Hywel C Williams. (2016) A programme of research to set priorities and reduce uncertainties for the prevention and treatment of skin disease. Programme Grants for Applied Research 4:18, pages 1-488.
Crossref
Crossref
Michael R. Ardern‐Jones, Carsten Flohr, Nick J. Reynolds & Colin A. Holden. 2016. Rook's Textbook of Dermatology, Ninth Edition. Rook's Textbook of Dermatology, Ninth Edition
1
46
.
Hidehisa Saeki, Takeshi Nakahara, Akio Tanaka, Kenji Kabashima, Makoto Sugaya, Hiroyuki Murota, Tamotsu Ebihara, Yoko Kataoka, Michiko Aihara, Takafumi Etoh & Norito Katoh. (2016) Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016. The Journal of Dermatology 43:10, pages 1117-1145.
Crossref
Crossref
Joris A. Broeders, Usama Ahmed Ali & Gayle Fischer. (2016) Systematic review and meta-analysis of randomized clinical trials (RCTs) comparing topical calcineurin inhibitors with topical corticosteroids for atopic dermatitis: A 15-year experience. Journal of the American Academy of Dermatology 75:2, pages 410-419.e3.
Crossref
Crossref
Yi-Ping Fang, Sien-Hung Yang, Chih-Hung Lee, Ibrahim A. Aljuffali, Hsiao-Ching Kao & Jia-You Fang. (2016) What is the discrepancy between drug permeation into/across intact and diseased skins? Atopic dermatitis as a model. International Journal of Pharmaceutics 497:1-2, pages 277-286.
Crossref
Crossref
Helen Nankervis, Alison Devine, Hywel C Williams, John R Ingram, Elizabeth Doney, Finola Delamere, Sherie Smith & Kim S Thomas. (2015) Validation of the global resource of eczema trials (GREAT database). BMC Dermatology 15:1.
Crossref
Crossref
Jade Cury Martins, Ciro Martins, Valeria Aoki, Aecio FT Gois, Henrique A Ishii & Edina MK da Silva. (2015) Topical tacrolimus for atopic dermatitis. Cochrane Database of Systematic Reviews 2016:10.
Crossref
Crossref
Brian Keng Yong Chia & Hong Liang Tey. (2015) Systematic Review on the Efficacy, Safety, and Cost-Effectiveness of Topical Calcineurin Inhibitors in Atopic Dermatitis. Dermatitis 26:3, pages 122-132.
Crossref
Crossref
Laurent Barnes, Gurkan Kaya & Victoria Rollason. (2015) Topical Corticosteroid-Induced Skin Atrophy: A Comprehensive Review. Drug Safety 38:5, pages 493-509.
Crossref
Crossref
Susanne Herbst, Anand Shah, Maria Mazon Moya, Vanessa Marzola, Barbara Jensen, Anna Reed, Mark A Birrell, Shinobu Saijo, Serge Mostowy, Sunil Shaunak & Darius Armstrong‐James. (2015)
Phagocytosis‐dependent activation of a
TLR
9–
BTK
–calcineurin–
NFAT
pathway co‐ordinates innate immunity to
Aspergillus fumigatus
. EMBO Molecular Medicine 7:3, pages 240-258.
Crossref
Crossref
Seul Ji Lee, Sung-il Woo, Soo Hyun Ahn, Dong Kyu Lim, Ji Yeon Hong, Jeong Hill Park, Johan Lim, Mi-kyeong Kim & Sung Won Kwon. (2014) Functional interpretation of metabolomics data as a new method for predicting long-term side effects: treatment of atopic dermatitis in infants. Scientific Reports 4:1.
Crossref
Crossref
Kim Thomas, Carolyn Charman, Helen Nankervis, Jane Ravenscroft & Hywel C. Williams. 2014. Evidence‐Based Dermatology. Evidence‐Based Dermatology
136
168
.
Jonathan I. Silverberg. (2014) Atopic Dermatitis: An Evidence-Based Treatment Update. American Journal of Clinical Dermatology 15:3, pages 149-164.
Crossref
Crossref
S.G. Danby, J. Chittock, K. Brown, L.H. Albenali & M.J. Cork. (2014) The effect of tacrolimus compared with betamethasone valerate on the skin barrier in volunteers with quiescent atopic dermatitis. British Journal of Dermatology 170:4, pages 914-921.
Crossref
Crossref
Emily Y. Gan, Sophie C. S. Cai & Mark B. Y. Tang. 2014. Filaggrin. Filaggrin
279
291
.
Warner W. Carr. (2013) Topical Calcineurin Inhibitors for Atopic Dermatitis: Review and Treatment Recommendations. Pediatric Drugs 15:4, pages 303-310.
Crossref
Crossref
D. Torley, M. Futamura, H. C. Williams & K. S. Thomas. (2013) What's new in atopic eczema? An analysis of systematic reviews published in 2010-11. Clinical and Experimental Dermatology 38:5, pages 449-456.
Crossref
Crossref
Andrew N. Lin. 2013. Comprehensive Dermatologic Drug Therapy. Comprehensive Dermatologic Drug Therapy
535
542.e4
.
Natalija Novak, Thomas Bieber, Matthias Hoffmann, Regina Fölster-Holst, Bernhard Homey, Thomas Werfel, Angelika Sager & Torsten Zuberbier. (2012) Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis. Journal of Allergy and Clinical Immunology 130:4, pages 925-931.e4.
Crossref
Crossref
Pallavi V. Pople & Kamalinder K. Singh. (2012) Targeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitis—Part II: In vivo assessment of dermatopharmacokinetics, biodistribution and efficacy. International Journal of Pharmaceutics 434:1-2, pages 70-79.
Crossref
Crossref
Kentaro Yomogida, Yuan Chou, Jonathan Pang, Bobby Baravati, Brian J. Maniaci, Shili Wu, Yong Zhu & Cong-Qiu Chu. (2012) Streptavidin suppresses T cell activation and inhibits IL-2 production and CD25 expression. Cytokine 58:3, pages 431-436.
Crossref
Crossref
Melakuu Tesfaye, Meseret Ewunetu Kibret & Tatek Temesgen Terfasa. (2021) In-Situ Oligomerization of Lactic Acid with in Broiler Skin Extracted Elastin/Collagen Matrix for the Efficacy of Ointment Base. SSRN Electronic Journal.
Crossref
Crossref